New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
14:25 EDTBA, BA, LLY, LLYSenate Judiciary Committee to hold a hearing
The Subcommittee on Crime and Terrorism holds a hearing entitled, "Economic Espionage and Trade Secret Theft: Are Our Laws Adequate for Today’s Threats? with Vice President Paul Hoffman of The Boeing Company and Vice President Doug Norman of Eli Lilly & Company on May 13 at 2:30 pm. Webcast Link
News For BA;LLY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
19:31 EDTBABoeing has no plans for long-range 737 MAX, Reuters reports
Boeing has no plans to extend the range of its upcoming 737 MAX 9 jetliner after Airbus Group's announcement that it will offer a long-range version of its competing A321 aircraft, according to Reuters, citing a senior Boeing executive. Reference Link
15:35 EDTBADelta Air Lines confirms order for 25 Airbus A350-900, 25 A330neo aircraft
Subscribe for More Information
13:50 EDTBABoeing confirms Kuwait Airways intent to purchase 10 777-300ERs
Subscribe for More Information
07:44 EDTBADelta near deal for 50 Airbus wide-body jets, Bloomberg reports
Subscribe for More Information
November 19, 2014
17:13 EDTBABoeing awarded $194.78M government contract modification
Subscribe for More Information
November 17, 2014
16:04 EDTLLYEli Lilly says empagliflozin tablets reduced A1C, body weight and abdominal fat
Empagliflozin tablets reduced hemoglobin A1C (a measure of average blood sugar over the past two to three months), body weight and several markers of abdominal fat in adults with type 2 diabetes, according to a new retrospective analysis of clinical trial data presented on behalf of Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company at the 2014 Scientific Sessions of the American Heart Association in Chicago. Abdominal fat, also known as visceral fat, sits on or near vital organs. The study presented at AHA included analyses of two sets of adults with T2D treated with either empagliflozin or placebo. The first group consisted of 823 adults with high blood pressure who were treated for 12 weeks, while the second examined a pool of 2,476 adults from four different trials who were treated for 24 weeks. These randomized studies compared empagliflozin with placebo as an add-on to existing therapy, including metformin, metformin plus sulfonylurea, or pioglitazone with or without metformin. In both groups, treatment with empagliflozin significantly reduced A1C, body weight and several markers of abdominal fat compared with placebo. Changes in estimated total body fat did not reach statistical significance.
11:06 EDTLLYLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
05:12 EDTBABoeing signs agreement with Toray Industries for 777X wing composites
Subscribe for More Information
November 14, 2014
14:53 EDTLLYCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
November 13, 2014
13:32 EDTLLYLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
13:29 EDTLLYLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
13:26 EDTLLYLeerink biotech analysts hold an analyst/industry conference call
Biotech Analysts provide a preview of items being discussed at the upcoming 56th Annual Meeting of ASH including Leukemia/MDS on an Analyst/Industry conference call to be held on November 20 at 10 am.
12:52 EDTBABoeing reports 90 new orders since last update
Subscribe for More Information
07:12 EDTBAOracle to hold a meeting
2014 OAGi Plenary Meeting is being held in Redwood City, California on November 13-14.
November 12, 2014
07:10 EDTBAFly Leasing to sell 8 Boeing 757 aircraft
Subscribe for More Information
November 11, 2014
16:14 EDTLLYLeerink biotech analysts hold an analyst/industry conference call
Biotech Analysts provide a preview of items being discussed at the upcoming 56th Annual Meeting of ASH including JAK inhibitors, novel Jakafi combinations for Myelofibrosis and developing compounds on an Analyst/Industry conference call to be held on November 17 at 10 am.
November 10, 2014
07:12 EDTBACA Technologies to hold a conference
CA World 2014 is being held in Las Vegas on November 9-12.
05:29 EDTBABoeing, SMBC Aviation announce order for 80 737 MAXs
Boeing and SMBC Aviation Capital announced an order for 80 737 MAX 8s, valued at more than $8.5B at list prices. This is the largest single order for 737 MAXs from a leasing company and will help SMBC Aviation Capital grow its portfolio of high-demand, fuel-efficient airplanes. Boeing's Current Market Outlook forecasts that airlines will need more than 25,600 single-aisle airplanes like the 737 MAX over the next 20 years.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use